Risk scoring improved clinical decisions and outcomes in high-risk patients with early-stage diabetic kidney disease

New, real-world evidence demonstrating that the KidneyIntelX bioprognostic test resulted in changed clinical decision making for patients in the early stage of diabetic kidney disease (DKD) being cared for within …

Risk scoring improved clinical decisions and outcomes in high-risk patients with early-stage diabetic kidney disease Read More